OPTIMAL INDICATION OF GANCYCLOVIR TREATMENT DURING EARLY CYTOMEGALOVIRUS (CMV) VIREMIA IN CMV-SEROPOSITIVE RECIPIENTS - A LONGITUDINAL-STUDY OF CMV-PP65 ANTIGENEMIA ASSAY

Authors
YANG CW LEE SH YOON SN AN HJ KIM YO SHIN YS KIM YS CHOI EJ BANG BK
Citation
Cw. Yang et al., OPTIMAL INDICATION OF GANCYCLOVIR TREATMENT DURING EARLY CYTOMEGALOVIRUS (CMV) VIREMIA IN CMV-SEROPOSITIVE RECIPIENTS - A LONGITUDINAL-STUDY OF CMV-PP65 ANTIGENEMIA ASSAY, Kidney international, 51(3), 1997, pp. 961-961
Citations number
NO
Categorie Soggetti
Urology & Nephrology
Journal title
Kidney international → ACNP
ISSN journal
00852538
Volume
51
Issue
3
Year of publication
1997
Pages
961 - 961
Database
ISI
SICI code
0085-2538(1997)51:3<961:OIOGTD>2.0.ZU;2-O